Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens

Positive Findings Support Potential Expanded Uses for ParidiprubartTORONTO, ON / ACCESSWIRE / June 28, 2023 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, …